Literature DB >> 23524338

Activation of SRE and AP1 by olfactory receptors via the MAPK and Rho dependent pathways.

Naïma Benbernou1, Stéphane Esnault, Francis Galibert.   

Abstract

Whereas the activation of MAPKs (mitogen activated kinases) and Rho dependant pathways by GPCR (G protein coupled receptors) has been the subject of many studies, its implication in the signalling of olfactory receptors, which constitute the largest GPCR family, has been far less analysed. Using an in vitro heterologous system, we showed that odorant activated ORs activate SRE containing promoters via the ERK pathway. We also demonstrated that RhoA and Rock kinases but not Rac were involved in ORs-induced SRE/SRF activation and that AP1 was activated, via JNK and p38 MAPKinase. Using real time PCR we found that mOR23, RnI7 and CfOR12A07 induced elevated levels of transcription factors ELK-4, srf, c-fos and c-jun mRNAs whereas mOREG induced an elevated transcription levels of c-fos and c-jun mRNA only. We showed also that odorant activated ORs stimulate the downstream MAPKs and Rho pathways in primary cultures of rat olfactory sensory neurons (OSNs). Similar results were also obtained with OE (olfactory epithelium) extracts prepared from rats exposed to odorants in vivo. Finally, we showed the important role of the AKT and MAPK signalling pathways in OSNs survival. Taken together, these data provide direct evidence that the binding of odorants onto their ORs activates the MAPK and Rho signalling pathways that are involved in OSNs survival events. This suggests that these pathways could be implicated in the regulation of OSNs homeostasis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524338     DOI: 10.1016/j.cellsig.2013.02.019

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

1.  Early survival factor deprivation in the olfactory epithelium enhances activity-driven survival.

Authors:  Adrien François; Iman Laziz; Stéphanie Rimbaud; Denise Grebert; Didier Durieux; Edith Pajot-Augy; Nicolas Meunier
Journal:  Front Cell Neurosci       Date:  2013-12-24       Impact factor: 5.505

2.  Revisiting olfactory receptors as putative drivers of cancer.

Authors:  Marco Ranzani; Vivek Iyer; Ximena Ibarra-Soria; Martin Del Castillo Velasco-Herrera; Mathew Garnett; Darren Logan; David J Adams
Journal:  Wellcome Open Res       Date:  2017-02-10

3.  Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis.

Authors:  Liming Pan; Mengting Sheng; Zirui Huang; Zhilin Zhu; Chunli Xu; Lin Teng; Ling He; Chen Gu; Cai Yi; Junming Li
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

4.  Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study.

Authors:  Eunkyung Lee; Cristiane Takita; Jean L Wright; Susan H Slifer; Eden R Martin; James J Urbanic; Carl D Langefeld; Glenn J Lesser; Edward G Shaw; Jennifer J Hu
Journal:  Hum Genomics       Date:  2019-06-13       Impact factor: 4.639

5.  SB203580, a p38MAPK inhibitor, attenuates olfactory dysfunction by inhibiting OSN apoptosis in AR mice (activation and involvement of the p38 mitogen-activated protein kinase in olfactory sensory neuronal apoptosis of OVA-induced allergic rhinitis).

Authors:  Xian Gao; Na Li; Jisheng Zhang
Journal:  Brain Behav       Date:  2019-04-30       Impact factor: 2.708

6.  Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.

Authors:  Cielito C Reyes-Gibby; Jian Wang; Mary Rose T Silvas; Robert K Yu; Ehab Y Hanna; Sanjay Shete
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

7.  Microarray and metabolome analysis of hepatic response to fasting and subsequent refeeding in zebrafish (Danio rerio).

Authors:  Jirong Jia; Jingkai Qin; Xi Yuan; Zongzhen Liao; Jinfeng Huang; Bin Wang; Caiyun Sun; Wensheng Li
Journal:  BMC Genomics       Date:  2019-12-02       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.